Zoom Corporation
Supplementary Materials for the Third Quarter of the Fiscal Year Ending December 2026
Achieved profitability in 3Q standalone; recovery driven by HAR, PFR, and DMX. 3Q cumulative revenue up 12.8% Year-over-Year, 3Q net income returned to a profit of 320 million yen. Full-year plan unchanged: operating income 740 million yen, progress 83.1%. New product news including NEURIG.
Key Figures
- Revenue: Unknown
- Operating Income: Unknown
- Dividend per Share: Unknown
AI要約
Overview of Performance
Profitability improvements continued in the standalone 3Q, with a turnaround from an operating loss in the same period last year to an operating profit. Recovery across key categories expanded to HAR, PFR, and DMX, and actual sales in North America also improved. 3Q cumulative revenue increased Year-over-Year, and operating income remained in the black. As planned for the full year, operating income is 740 million yen with a progress rate of 83.1%, and the dividend forecast is unchanged.
Outlook and Topics
There were neural-focused demos centered on NEURIG and announcements of new products, garnering increased interest from guitar communities domestically and internationally. By region and product, expansion of DMX and PFR continued, and recovery breadth expanded mainly in North America and Europe. The full-year forecast is maintained for now, while monitoring impacts from external factors.
Zoom Corporation
Company overview · Stock price · Financial data · All IR
